{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:4594",
      "entity_text" : "result",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "IL6",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Plasma levels of human soluble IL6R and human IL6 were elevated after 4-week treatment of tocilizumab in this mouse model similarly to the result previously reported in patients treated with tocilizumab.",
  "reading_complete" : "2020-08-04T09:02:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:01:17Z",
  "trigger" : "elevated",
  "evidence" : [ "IL6 were elevated after 4-week treatment of tocilizumab in this mouse model similarly to the result" ],
  "pmc_id" : "3561642",
  "score" : 0
}